Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine and Gemcitabine in Biliary Tract and Gallbladder Cancer
NCT00075504Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2003
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triapine in biliary tract cancer (BTC), gallbladder cancer, sponsored by National Cancer Institute. Started Nov 2003; status: completed.
02
Drugs
triapine
03
Conditions
biliary tract cancer (BTC)gallbladder cancer
Beyond the preview
Go deeper on NCT00075504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075504.